Jaguar Health's three largest insider shareholders as of September 29, 2026 are Gregory J Divis (Director, 0 shares), Lisa A Conte (Ceo And President, 0 shares), Steven R. King (Chief Of Sustainable Supply, 0 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Gregory J Divis | Director | 0 | 0 | 0 | 100.0% | 18 May, 2022 |
| 2 | John Micek | Director | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
| 3 | James J Bochnowski | Director | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
| 4 | Jonathan B. Siegel | Director | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
| 5 | Steven R. King | Chief Of Sustainable Supply | 0 | 0 | 0 | 0.0% | 21 Jan, 2026 |
| 6 | Carol R. Lizak | Chief Financial Officer | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
| 7 | Jonathan S. Wolin | Chief Of Staff, Cco Gc | 0 | 0 | 0 | 0.0% | 21 Jan, 2026 |
| 8 | Anula Jayasuriya | Director | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
| 9 | Lisa A Conte | Ceo And President | 0 | 0 | 0 | 0.0% | 21 Jan, 2026 |
| 10 | Pravin R Chaturvedi | Chief Scientific Officer | 0 | 0 | 0 | 0.0% | 15 Dec, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Dec, 2025 | Jonathan S. Wolin | Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Steven R. King | Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Lisa A Conte | Director, Officer | Acquired A | 28,592 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Steven R. King | Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Jonathan S. Wolin | Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Lisa A Conte | Director, Officer | Acquired A | 28,592 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Anula Jayasuriya | Director | Acquired A | 5,870 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Jonathan B. Siegel | Director | Acquired A | 7,377 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | John Micek | Director | Acquired A | 7,377 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | James J Bochnowski | Director | Acquired A | 6,363 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Pravin R Chaturvedi | Chief Scientific Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Carol R. Lizak | Chief Financial Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Jonathan B. Siegel | Director | Acquired A | 7,377 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Anula Jayasuriya | Director | Acquired A | 5,870 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | James J Bochnowski | Director | Acquired A | 6,363 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Pravin R Chaturvedi | Chief Scientific Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Carol R. Lizak | Chief Financial Officer | Acquired A | 11,740 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | John Micek | Director | Acquired A | 7,377 | $0.00 | $0 | 0 | Direct |
| 24 Jun, 2025 | Lisa A Conte | Ceo And President | Disposed D | 9,000 | $619,976,491,237,226.00 | $5,579,788.42Tn | 0 | Direct |
| 24 Jun, 2025 | James J Bochnowski | Director | Disposed D | 27,002 | $1,859,929,473,711,677.75 | $50,221,815.65Tn | 0 | Indirect |